1 – 10 of 22
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Regional differences in treatment and outcome for myeloma patients in Sweden : A population based Swedish myeloma register study
(
- Contribution to journal › Article
-
Mark
Outcome data from >10 000 multiple myeloma patients in the Danish and Swedish national registries
(
- Contribution to journal › Article
- 2021
-
Mark
Comorbidities in multiple myeloma and implications on survival : A population-based study
(
- Contribution to journal › Article
-
Mark
Autoimmune disease is associated with a lower risk of progression in monoclonal gammopathy of undetermined significance
(
- Contribution to journal › Article
-
Mark
Cumulative exposure to melphalan chemotherapy and subsequent risk of developing acute myeloid leukemia and myelodysplastic syndromes in patients with multiple myeloma
(
- Contribution to journal › Article
-
Mark
Untangling fracture risk in monoclonal gammopathy of undetermined significance : A population-based cohort study
(
- Contribution to journal › Article
- 2020
-
Mark
Outcome and characteristics of non-measurable myeloma : A cohort study with population-based data from the Swedish Myeloma Registry
(
- Contribution to journal › Article
-
Mark
Second malignancies in multiple myeloma; emerging patterns and future directions
(
- Contribution to journal › Scientific review
- 2019
-
Mark
Parental longevity and survival among patients with multiple myeloma and monoclonal gammopathy of undetermined significance : a population-based study
(
- Contribution to journal › Article
- 2018
-
Mark
Chemerin is elevated in multiple myeloma patients and is expressed by stromal cells and pre-adipocytes
(
- Contribution to journal › Letter